share_log

Baird Initiates Coverage On Xenon Pharmaceuticals With Outperform Rating, Announces Price Target of $63

Baird Initiates Coverage On Xenon Pharmaceuticals With Outperform Rating, Announces Price Target of $63

贝尔德以跑赢大盘的评级启动对Xenon Pharmicals的报道,宣布目标股价为63美元
Benzinga ·  2023/12/08 05:29

贝尔德分析师布莱恩·斯科尼开始对Xenon Pharmicals(纳斯达克股票代码:XENE)进行报道,评级为跑赢大盘,并宣布目标股价为63美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发